|
|
Analysis of clinical value of Pituitrin and Methotrexate for the treatment of tubal pregnancy under laparoscopy |
WEN Li-ping |
Department of Gynaecology,People′s Hospital of Zijin County,Guangdong Province,Zijin517400,China |
|
|
Abstract Objective To observe and analyze the clinical value of Pituitrin and Methotrexate for the treatment of tubal pregnancy under laparoscopy.Methods Sixty cases of laparoscopic tubal pregnancy and who treated by laparoscopic in our hospital from January to October in 2016 were selected as the research objects,and were divided into two groups,study group and control group,with 30 cases in each group.Patients in the study group were treated with local injection of Pituitrin and Methotrexate while patients in the control group were not treated with drug.Then,the operation time,the amount of bleeding,the bleeding time,the changes of the level of β-HCG after operation and the occurrence of postoperative persistent ectopic pregnancy of patients in the two groups were compared.Results The operation time,bleeding volume,bleeding time in the study group were significantly better than those in the control group,the differences were statistically significant(P<0.01);the decreased level of β-HCG in the study group 1,2 weeks after operation was significantly lower than that in the control group,the difference was statistically significant(P<0.01);the incidence rate of persistent ectopic pregnancy and tubal patency rate of patients after operation in the study group were significantly better than those in the control group,and the differences were statistically significant(P<0.01).Conclusion The injection of Pituitrin and Methotrexate in patients with tubal pregnancy undergoing laparoscopic can effectively protect the fallopian tube of patients,reduce the operation time and the amount of bleeding,and significantly lower the incidence of persistent ectopic pregnancy,it have significant benefits for patients with pregnancy,thus it is worthy to be promoted and applied in clinical.
|
|
|
|
|
[1] |
董琳琳,汤明军,吕文韬,等.腹腔镜下输卵管保守性手术联合氨甲蝶呤局部治疗未破裂输卵管妊娠56例临床体会[J].临床合理用药杂志,2016,9(22):99-100.
|
[2] |
杨娟,张庆华.垂体后叶素联合甲氨蝶呤用于腹腔镜下输卵管妊娠切开术60例分析[J].实用妇产科杂志,2014,30(3):232-234.
|
[3] |
尹淑萍.腹腔镜输卵管妊娠保守性手术联合药物临床探讨[J].中国医刊,2013,48(12):84-86.
|
[4] |
覃艳芬,吴丽英,覃花婵,等.腹腔镜保守治疗输卵管妊娠148例临床疗效分析[J].中国临床新医学,2013,6(7):657-659.
|
[5] |
布占红,熊小琴.甲氨蝶呤联合垂体后叶素在腹腔镜输卵管妊娠切开取胚术中应用分析[J].中外医学研究,2015,22(3):1-3.
|
[6] |
焦蓉,陈琼华.垂体后叶素及甲氨蝶呤在输卵管妊娠腹腔镜下保守治疗中的应用[J].中国妇幼保健,2013,28(33):5541-5542.
|
[7] |
李群英,熊丽,周金桃,等.腹腔镜输卵管妊娠保守性手术应用垂体后叶素联合甲氨蝶呤临床观察[J].山西医药杂志,2013,42(6):288-290.
|
[8] |
覃艳芬,吴丽英,石慧娟,等.甲氨蝶呤联合垂体后叶素用于输卵管妊娠腹腔镜保守手术中的疗效观察[J].中国妇幼保健,2014,29(28):4643-4645.
|
[9] |
潘丽琴.用垂体后叶素与甲氨蝶呤辅助腹腔镜手术治疗异位妊娠的效果观察[J].当代医药论丛,2014,31(5):243-244.
|
[10] |
张霞,于蕾,高晨,等.垂体后叶素联合甲氨蝶呤在异位妊娠腹腔镜保守性手术中的应用研究[J].黑龙江医学,2015,25(9):1033-1035.
|
[11] |
杨先梅.未破裂型输卵管妊娠不同手术时机输卵管功能状态的探讨[J].中国实用医药,2015,13(27):85-87.
|
[12] |
黄骊莉,赵艳,陈晓辉,等.腹腔镜下保守手术对异位妊娠输卵管功能恢复的探讨[J].医学临床研究,2014,24(4):797-798.
|
[13] |
黄启涛,李银,陈夏珠,等.腹腔镜下保守手术及根治手术治疗输卵管妊娠生育结局的Meta分析[J].实用妇产科杂志,2013,29(10):757-761.
|
[14] |
邢延玲,张英.经阴道宫腔镜手术与腹腔镜手术治疗输卵管妊娠的疗效比较[J].广东医学,2013,34(17):2696-2698.
|
[15] |
崔芳,徐珊,史红,等.甲氨蝶呤不同给药方法联合腹腔镜手术治疗输卵管妊娠[J].中华医学杂志,2015,95(45):3663-3666.
|
|
|
|